LAVAL, QC en CAMBRIDGE, Engeland, 5 juni 2023 /PRNewswire/ — Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” of het “Bedrijf”) maakte de stemresultaten van zijn Jaarlijkse Algemene Vergadering van Aandeelhouders (“AVA”) bekend die op 5 juni 2023 virtueel gehouden werd. In…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.